Loading...
XHKG0853
Market cap1.46bUSD
Dec 23, Last price  
6.15HKD
1D
-0.32%
1Q
13.89%
Jan 2017
5.31%
IPO
-24.54%
Name

Microport Scientific Corp

Chart & Performance

D1W1MN
XHKG:0853 chart
P/E
P/S
1.54
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
3.17%
Rev. gr., 5y
7.27%
Revenues
951m
+13.07%
82,121,678109,718,029133,627,525149,149,365154,891,885355,284,000375,844,000389,921,000444,190,000669,490,000793,493,000648,732,000778,639,000840,831,000950,725,000
Net income
-478m
L-18.79%
27,295,44136,200,02351,050,91456,711,11424,509,095-59,461,000-12,086,00014,141,00018,823,00023,913,00029,009,000-223,348,000-351,295,000-588,115,000-477,629,000
CFO
-232m
L-32.46%
29,718,40929,564,78747,753,38145,753,71559,001,62317,806,00030,720,00082,534,00097,186,00084,130,00026,451,000-23,200,000-257,530,000-343,303,000-231,873,000
Dividend
Jun 28, 20210.043 HKD/sh
Earnings
Mar 26, 2025

Profile

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.
IPO date
Sep 24, 2010
Employees
8,884
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
950,725
13.07%
840,831
7.99%
778,639
20.02%
Cost of revenue
1,338,787
1,339,914
1,145,131
Unusual Expense (Income)
NOPBT
(388,062)
(499,083)
(366,492)
NOPBT Margin
Operating Taxes
22,642
6,597
13,971
Tax Rate
NOPAT
(410,704)
(505,680)
(380,463)
Net income
(477,629)
-18.79%
(588,115)
67.41%
(351,295)
57.29%
Dividends
(6,423)
Dividend yield
0.01%
Proceeds from repurchase of equity
4,658
(41,030)
1,032,867
BB yield
-0.03%
0.11%
-2.01%
Debt
Debt current
798,987
237,331
145,251
Long-term debt
1,032,002
1,406,932
1,317,385
Deferred revenue
62,962
61,341
Other long-term liabilities
358,564
220,997
428,804
Net debt
317,677
(689)
(791,781)
Cash flow
Cash from operating activities
(231,873)
(343,303)
(257,530)
CAPEX
(166,723)
(257,274)
(247,923)
Cash from investing activities
(376,808)
(412,752)
(655,743)
Cash from financing activities
434,897
272,996
1,660,268
FCF
(621,574)
(623,843)
(987,463)
Balance
Cash
1,130,672
1,241,208
1,754,414
Long term investments
382,640
403,744
500,003
Excess cash
1,465,776
1,602,910
2,215,485
Stockholders' equity
725,371
989,615
1,433,555
Invested Capital
2,734,937
2,537,488
2,498,652
ROIC
ROCE
EV
Common stock shares outstanding
1,823,930
1,817,910
1,812,922
Price
8.42
-59.03%
20.55
-27.64%
28.40
-31.32%
Market cap
15,357,491
-58.89%
37,358,049
-27.44%
51,486,985
-30.69%
EV
16,320,346
38,014,998
51,421,946
EBITDA
(236,817)
(357,736)
(273,013)
EV/EBITDA
Interest
92,732
73,912
42,710
Interest/NOPBT